52 related articles for article (PubMed ID: 19366048)
1. Progress in the use of immunotherapy to treat uterine cervical cancer.
De Lorenzo BH; Ramos Mde C; Michelin MA; Murta EF
Tumori; 2009; 95(1):1-7. PubMed ID: 19366048
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy in patients with local HPV infection and high-grade squamous intraepithelial lesion following uterine cervical conization.
Kovachev SM
Immunopharmacol Immunotoxicol; 2020 Aug; 42(4):314-318. PubMed ID: 32429720
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic vaccines for cervical cancer: dendritic cell-based immunotherapy.
Santin AD; Bellone S; Roman JJ; Burnett A; Cannon MJ; Pecorelli S
Curr Pharm Des; 2005; 11(27):3485-500. PubMed ID: 16248803
[TBL] [Abstract][Full Text] [Related]
4. [Preventive vaccines and immunotherapy clinical trials against cervical cancer].
Valdespino-Gómez VM
Cir Cir; 2005; 73(1):57-69. PubMed ID: 15888272
[TBL] [Abstract][Full Text] [Related]
5. Cervical Cancer Immunotherapy: Facts and Hopes.
Ferrall L; Lin KY; Roden RBS; Hung CF; Wu TC
Clin Cancer Res; 2021 Sep; 27(18):4953-4973. PubMed ID: 33888488
[TBL] [Abstract][Full Text] [Related]
6. Loop electrosurgical excision procedures for cervical dysplasia: experience in a community hospital.
Krebs HB; Pastore L; Helmkamp BF
Am J Obstet Gynecol; 1993 Aug; 169(2 Pt 1):289-93; discussion 293-5. PubMed ID: 8362938
[TBL] [Abstract][Full Text] [Related]
7. Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies.
Vici P; Pizzuti L; Mariani L; Zampa G; Santini D; Di Lauro L; Gamucci T; Natoli C; Marchetti P; Barba M; Maugeri-Saccà M; Sergi D; Tomao F; Vizza E; Di Filippo S; Paolini F; Curzio G; Corrado G; Michelotti A; Sanguineti G; Giordano A; De Maria R; Venuti A
Expert Rev Vaccines; 2016 Oct; 15(10):1327-36. PubMed ID: 27063030
[TBL] [Abstract][Full Text] [Related]
8. New approaches in vaccine-based immunotherapy for human papillomavirus-induced cancer.
van der Sluis TC; van der Burg SH; Arens R; Melief CJ
Curr Opin Immunol; 2015 Aug; 35():9-14. PubMed ID: 26001120
[TBL] [Abstract][Full Text] [Related]
9. Advances in immunotherapy for cervical cancer.
Wendel Naumann R; Leath CA
Curr Opin Oncol; 2020 Sep; 32(5):481-487. PubMed ID: 32740092
[TBL] [Abstract][Full Text] [Related]
10. Immune responses against virus and tumor in cervical carcinogenesis: treatment strategies for avoiding the HPV-induced immune escape.
Conesa-Zamora P
Gynecol Oncol; 2013 Nov; 131(2):480-8. PubMed ID: 23994536
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy and targeted therapy for cervical cancer: an update.
Menderes G; Black J; Schwab CL; Santin AD
Expert Rev Anticancer Ther; 2016; 16(1):83-98. PubMed ID: 26568261
[TBL] [Abstract][Full Text] [Related]
12. The role of human papillomavirus vaccines in cervical neoplasia.
Stern PL; Faulkner R; Veranes EC; Davidson EJ
Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):783-99. PubMed ID: 11563873
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer vaccines: progress and prospects.
Steller MA
J Soc Gynecol Investig; 2002; 9(5):254-64. PubMed ID: 12383909
[TBL] [Abstract][Full Text] [Related]
14. Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins.
Munro A; Codde J; Spilsbury K; Stewart CJ; Steel N; Leung Y; Tan J; Salfinger SG; Mohan GR; Semmens JB; Cohen PA
Acta Obstet Gynecol Scand; 2017 Apr; 96(4):432-437. PubMed ID: 28181670
[TBL] [Abstract][Full Text] [Related]
15. Research Progress of Immuno-Inhibitory Receptors in Gynecological Cervical Cancer.
Li Y; Shen F; Tan Q; Chen Y; Gu Y
Technol Cancer Res Treat; 2023; 22():15330338231208846. PubMed ID: 37908109
[TBL] [Abstract][Full Text] [Related]
16. [Ⅰ. Immunotherapy in Cervical Cancer-Current Approaches and Future Horizons].
Iwata T; Matsui T; Matsuda R; Katoh Y; Sugawara M; Nogami Y; Nishio H; Yamagami W
Gan To Kagaku Ryoho; 2024 Feb; 51(2):134-137. PubMed ID: 38449397
[No Abstract] [Full Text] [Related]
17. CALLA trial: immunotherapy in locally advanced cervical cancer - Authors' reply.
Monk BJ; Mayadev J
Lancet Oncol; 2024 Mar; 25(3):e96. PubMed ID: 38423064
[No Abstract] [Full Text] [Related]
18. A bibliometric analysis on research hot-spot and publication trends in immunotherapy for cervical cancer after surgery.
Zou D; Liang A
Asian J Surg; 2023 Aug; 46(8):3178-3179. PubMed ID: 36906421
[No Abstract] [Full Text] [Related]
19. The group with the most heterogenous treatment among patients with cervical cancer.
Cibula D
Gynecol Oncol; 2023 Aug; 175():191. PubMed ID: 37076336
[No Abstract] [Full Text] [Related]
20. Overtreatment by hysterectomy for cervical intraepithelial neoplasia: Medico-legal aspects.
Cecannecchia C; Cioffi F; Cioffi A
Int J Reprod Biomed; 2023 Jun; 21(6):521-522. PubMed ID: 37560065
[No Abstract] [Full Text] [Related]
[Next] [New Search]
